Posted by jkl77 on May 17, 2015, at 13:03:10
In reply to Re: Viibryd in Europe » joe f, posted by europerep on May 17, 2015, at 8:06:40
> Yeah, based on what I've heard and read, it doesn't seem to be a smashing success. I don't recall any poster here on PB who has had real success with it, and I remember reading that even its touted side effect profile is less good than was suggested before it was released.
>
> Maybe it's more of a new first-line drug, with slim (if any) advantages for treatment-resistant patients.In the US it is the third most popular antidepressant. More popular than all the SSRI:s. http://mentalhealthdaily.com/2014/08/30/most-popular-antidepressants-in-2014-cymbalta-pristiq-viibryd/
poster:jkl77
thread:1078997
URL: http://www.dr-bob.org/babble/20150407/msgs/1079025.html